EGFR Exon 19 Deletion Mutation

DrugDrug NameDrug Description
DB11963DacomitinibA medication used to treat non small cell lung cancer with EGFR exon 19 deletion of exon 21 L858R substitution.
DrugDrug NamePhaseStatusCount
DB09330Osimertinib1Recruiting1
DB11836Sapanisertib1Recruiting1
DB00112Bevacizumab2Active Not Recruiting1
DB00530Erlotinib2Active Not Recruiting1
DB09330Osimertinib2Recruiting1